Whan In Pharm Statistics

Total Valuation

Whan In Pharm has a market cap or net worth of KRW 177.25 billion. The enterprise value is 118.32 billion.

Market Cap	177.25B
Enterprise Value	118.32B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Dec 29, 2025

Share Statistics

Whan In Pharm has 15.27 million shares outstanding. The number of shares has increased by 1.53% in one year.

Current Share Class	15.27M
Shares Outstanding	15.27M
Shares Change (YoY)	+1.53%
Shares Change (QoQ)	+5.98%
Owned by Insiders (%)	28.36%
Owned by Institutions (%)	14.26%
Float	10.94M

Valuation Ratios

The trailing PE ratio is 11.86 and the forward PE ratio is 12.58.

PE Ratio	11.86
Forward PE	12.58
PS Ratio	0.69
PB Ratio	0.45
P/TBV Ratio	0.46
P/FCF Ratio	31.22
P/OCF Ratio	17.20
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.11, with an EV/FCF ratio of 20.84.

EV / Earnings	7.80
EV / Sales	0.46
EV / EBITDA	5.11
EV / EBIT	8.88
EV / FCF	20.84

Financial Position

The company has a current ratio of 5.55, with a Debt / Equity ratio of 0.00.

Current Ratio	5.55
Quick Ratio	3.24
Debt / Equity	0.00
Debt / EBITDA	0.03
Debt / FCF	0.13
Interest Coverage	456.42

Financial Efficiency

Return on equity (ROE) is 3.95% and return on invested capital (ROIC) is 2.02%.

Return on Equity (ROE)	3.95%
Return on Assets (ROA)	1.80%
Return on Invested Capital (ROIC)	2.02%
Return on Capital Employed (ROCE)	3.10%
Revenue Per Employee	426.49M
Profits Per Employee	25.24M
Employee Count	601
Asset Turnover	0.59
Inventory Turnover	2.20

Taxes

In the past 12 months, Whan In Pharm has paid 637.11 million in taxes.

Income Tax	637.11M
Effective Tax Rate	4.03%

Stock Price Statistics

The stock price has decreased by -3.34% in the last 52 weeks. The beta is 0.22, so Whan In Pharm's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	-3.34%
50-Day Moving Average	11,190.60
200-Day Moving Average	11,502.55
Relative Strength Index (RSI)	55.76
Average Volume (20 Days)	23,171

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Whan In Pharm had revenue of KRW 256.32 billion and earned 15.17 billion in profits. Earnings per share was 978.53.

Revenue	256.32B
Gross Profit	84.07B
Operating Income	12.45B
Pretax Income	15.80B
Net Income	15.17B
EBITDA	22.27B
EBIT	12.45B
Earnings Per Share (EPS)	978.53

Full Income Statement

Balance Sheet

The company has 59.69 billion in cash and 760.47 million in debt, giving a net cash position of 58.93 billion or 3,859.83 per share.

Cash & Cash Equivalents	59.69B
Total Debt	760.47M
Net Cash	58.93B
Net Cash Per Share	3,859.83
Equity (Book Value)	393.81B
Book Value Per Share	25,794.90
Working Capital	178.67B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.30 billion and capital expenditures -4.63 billion, giving a free cash flow of 5.68 billion.

Operating Cash Flow	10.30B
Capital Expenditures	-4.63B
Free Cash Flow	5.68B
FCF Per Share	371.87

Full Cash Flow Statement

Margins

Gross margin is 32.80%, with operating and profit margins of 4.86% and 5.92%.

Gross Margin	32.80%
Operating Margin	4.86%
Pretax Margin	6.17%
Profit Margin	5.92%
EBITDA Margin	8.69%
EBIT Margin	4.86%
FCF Margin	2.21%

Dividends & Yields

This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.58%.

Dividend Per Share	300.00
Dividend Yield	2.58%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	30.20%
Buyback Yield	-1.53%
Shareholder Yield	1.06%
Earnings Yield	8.56%
FCF Yield	3.20%

Dividend Details

Stock Splits

The last stock split was on April 14, 2010. It was a forward split with a ratio of 2.

Last Split Date	Apr 14, 2010
Split Type	Forward
Split Ratio	2

Scores

Whan In Pharm has an Altman Z-Score of 4.64 and a Piotroski F-Score of 4.

Altman Z-Score	4.64
Piotroski F-Score	4